HALOZYME PROVIDES 2022 FINANCIAL GUIDANCE AND OUTLOOK
Go back to HALOZYME PROVIDES 2022 FINANCIAL GUIDANCE AND OUTLOOK| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 67.37 +0.01 (0.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.36 | 52 Week High | $18.39 | |||
| Open | $66.80 | 52 Week Low | $6.96 | |||
| Day High | $68.00 | P/E | N/A | |||
| Day Low | $66.26 | EPS | $-0.58 | |||
| Volume | 1,263,287 | |||||
